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Abstract
Background—Magnetic resonance microscopy (MRM), magnetic resonance imaging (MRI) at
microscopic levels, provides unprecedented opportunities to aid in defining the full spectrum of
ethanol’s insult to the developing brain. This is the first in a series of reports that, collectively, will
provide an MRM-based atlas of developmental stage-dependent structural brain abnormalities in a
Fetal Alcohol Spectrum Disorders (FASD) mouse model. The ethanol exposure time and
developmental stage examined for this report is gestational day (GD) 8 in mice, when the embryos
are at early neurulation stages; stages present in humans early in the fourth week postfertilization.
Methods—For this study, pregnant C57Bl/6J mice were administered an ethanol dosage of 2.8 g/
kg intraperitoneally at 8 days, 0 hour and again at 8 days, 4 hours postfertilization. On GD 17, fetuses
that were selected for MRM analyses were immersion fixed in a Bouin’s/Prohance solution. Control
fetuses from vehicle-treated dams were stage-matched to those that were ethanol-exposed. The fetal
mice were scanned ex vivo at 7.0 T and 512 · 512 · 1024 image arrays were acquired using 3-D spin
warp encoding. The resulting 29 lm (isotropic) resolution images were processed using ITK-SNAP,
a 3-D segmentation/visualization tool. Linear and volume measurements were determined for
selected brain, head, and body regions of each specimen. Comparisons were made between control
and treated fetuses, with an emphasis on determining (dis)proportionate changes in specific brain
regions.
Results—As compared with controls, the crown-rump lengths of stage-matched ethanol-exposed
GD 17 fetuses were significantly reduced, as were brain and whole body volumes. Volume reductions
were notable in every brain region examined, with the exception of the pituitary and septal region,
and were accompanied by increased ventricular volumes. Disproportionate regional brain volume
reductions were most marked on the right side and were significant for the olfactory bulb,
hippocampus, and cerebellum; the latter being the most severely affected. Additionally, the septal
region and the pituitary were disproportionately large. Linear measures were consistent with those
of volume. Other dysmorphologic features noted in the MR scans were choanal stenosis and optic
nerve coloboma.
Conclusions—This study demonstrates that exposure to ethanol occurring in mice at stages
corresponding to the human fourth week postfertilization results in structural brain abnormalities
that are readily identifiable at fetal stages of development. In addition to illustrating the utility of MR
microscopy for analysis of an FASD mouse model, this work provides new information that confirms
and extends human clinical observations. It also provides a framework for comparison of structural
brain abnormalities resulting from ethanol exposure at other developmental stages and dosages.
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The impact of prenatal alcohol exposure on the brain is becoming increasingly evident (Abel,
2006; May et al., 2006). Indeed, within Fetal Alcohol Spectrum Disorder (FASD, the umbrella
term encompassing the spectrum of ethanol-related developmental abnormalities), which is
estimated to occur in at least 1% of all births, central nervous system (CNS) abnormalities
predominate. In spite of its prevalence, much remains to be learned regarding the structural
and functional damage to the brain caused by maternal alcohol use; knowledge that can be
applied to diagnosis, treatment and prevention.
The application of magnetic resonance imaging (MRI) to clinical FASD assessments is of great
importance in filling the gaps in our understanding of alcohol-induced CNS dysmorphology.
Results of MRI analyses of individuals with fullblown Fetal Alcohol Syndrome (FAS) were
first reported in the early 1990s (Mattson et al., 1992, 1994; Riley et al., 1995).
Reductions in the size of the basal ganglia, the corpus callosum, and lobules I–V of the
cerebellar vermis were observed. In addition to abnormal corpora callosa Swayze and
colleagues (1997) found that patients diagnosed with FAS may also exhibit other midline brain
abnormalities, such asseptum cavi pellucidi and cavum vergae. Another MRI-based study of
the corpus callosum illustrated that changes occur in the shape of this fiber tract even in
individuals without the facial features of FAS (Bookstein et al., 2002). Children exposed
prenatally (either with or without a diagnosis of full FAS) have also been shown to have
hypoplastic cerebellar vermis and hemispheres, as well as small hippocampi (Autti-Rämö et
al., 2002). In MRI studies by Cortese and colleagues (2006), deficiencies involving the caudate
nucleus have been documented in the absence of the full FAS phenotype. Recently, MRI studies
of children with heavy prenatal alcohol exposure have also illustrated abnormal cortical
thickness in temporal, parietal, and frontal cortical regions (Sowell et al., 2008).
Although human imaging studies continue to increase our knowledge of the range and pattern
of ethanol-induced defects in humans, they cannot readily provide the controlled, rapid, and
comprehensive analyses allowed by application of advanced imaging methodologies to studies
of experimental animal models. Johnson and colleagues were the first to observe the utility of
magnetic resonance microscopy (MRM) for studying anatomy in fixed tissues using MRI at
microscopic levels (Johnson et al., 1993). These methods have recently been used to acquire
a complete atlas of the mouse at gestational day (GD) 10.5 – postnatal day (PD) 32 (Petiet et
al., 2008). Others have recently shown that a powerful use of MRM at a resolution of 25.4 ·
25.4 · 26 lm is for high throughput, phenotype-driven screens for developmental malformations
in mouse models of human birth defects (Schneider et al., 2004). This approach has, for
example, provided sufficient detail to visualize and characterize abnormal cardiovascular
anatomy in fetal mice, without the need for labor intensive histological sectioning. Herein, we
present the results of a similar approach to the study of alcohol-induced structural brain
abnormalities in an FASD model.
Numerous studies of FASD animal models have collectively illustrated that alcohol induces
CNS abnormalities in a developmental-stage and dosage-dependent manner [National Institute
on Alcohol Abuse and Alcoholism (NIAAA), 2000; Randall, 1987]. Major structural
abnormalities, including those of the brain, are typically the result of insult during embryonic
stages of development. Consequently, this developmental period has been initially targeted for
MRI investigations. This work employs a C57Bl/6J mouse model that, following acute
maternal ethanol administration at selected embryonic stages, has previously been shown to
present with CNS abnormalities and all of the salient craniofacial features of FAS, as well as
other stage-dependent abnormalities in other organ systems (Cook and Sulik, 1986; Cook et
al., 1987; Daft et al., 1986; Dunty et al., 2001; Gage and Sulik, 1991; Kotch and Sulik, 1992;
Kotch et al., 1992; Schambra et al., 1990; Sulik, 1984; Sulik and Johnston, 1982; Sulik et al.,
1981; Webster et al.,1983). Importantly, the presence of externally visible anomalies of the
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face and eyes has previously been shown to be indicative of concurrent CNS insult in this acute
exposure FASD model (Cook et al., 1987; Sulik, 2005; Sulik and Johnston, 1983).
Toward the long-term goal of identifying the full range of structural CNS defects that prenatal
ethanol exposure can cause, we have initiated MRM analyses of animals that are expected to
exhibit the severe end of the spectrum of insult. Identification of vulnerable brain regions in
severely affected animals will, undoubtedly, provide clues that will facilitate discovery of more
subtle manifestations of ethanol’s insult. This approach is similar to selecting children with
known physical features of FAS for subsequent CNS studies.
Even though C57Bl/6J mice are inbred, an acute maternal dose of ethanol commonly yields
considerable intra-litter variability with respect to degree of effect. For example, among a litter
whose mother is given ethanol on just day 7 of her pregnancy, it is common for some pups to
present with apparently normal craniofacies, while others have the typical facies of FAS, or of
holoprosencephaly (Sulik and Johnston, 1982). That within a single litter (even among
controls), there is a range of embryonic stages representing as much as 12 hours of
development, probably explains a great deal of this phenotypic variability.
Frequently, the most severely affected pups in an ethanolexposed litter die (most likely, due
to non-CNS-related defects) or are cannibalized by their mothers shortly after birth. With the
hope of identifying even the most severe ethanol-induced structural brain abnormalities, it is,
therefore, necessary to conduct prenatal examinations. Pilot feasibility studies utilizing a 7.0
T magnet have illustrated that GD 17, 2–3 days before birth, is an optimal time for MRM
analyses of fetal mouse brains (Petiet et al., 2007). At this stage, the fetuses can be
noninvasively fixed by immersion in a contrast-enhancing solution (Petiet et al., 2007) that
affords very high-resolution (29 lm) imaging. Importantly, the imaging procedure is such that
the scans are isotropic, thus allowing accurate 3-D reconstruction and subsequent volume
assessments.
For this report, which is the first in a series that, collectively, is designed to provide an MRM-
based atlas of developmental stage-dependent structural brain abnormalities in a FASD mouse
model, the ethanol exposure time examined is GD 8. At this time of development, the embryos
are at early neurulation stages; stages present in humans early in the fourth week
postfertilization. Ex vivo MRM was conducted on developmental stage-matched control and
ethanol-exposed GD 17 fetuses. The degree of brain development on GD 17 in mice
corresponds approximately to that in weeks 12–13 in human fetuses (Clancy et al., 2007); a
time when prenatal diagnostic imaging is feasible and is becoming increasingly common. The
images acquired for this study were utilized to provide both linear and volumetric measures
and to define the ethanol-induced collection of structural brain abnormalities.
Animal Maintenance
C57Bl/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed
on a 12/12 hours light/dark cycle in a temperature and humidity controlled, AAALAC-
approved environment. The mice were maintained on an ad lib diet of standard laboratory chow
and water before and after treatment. Female mice were bred for a 2 hours period by placing
1–2 females with 1 male. Gestational day 0 was defined as the beginning of the breeding period
in which a copulation plug was found.
Maternal Treatment Paradigm
On day 8 of pregnancy, mice were randomly assigned to either an ethanol or control group.
The mice in the ethanol group were administered 2 intraperitoneal doses of 23.7% (v/v) ethanol
(2.8 g/kg – each dose) on GD 8, 0 hour and GD 8, 4 hours. Control dams were administered
Parnell et al. Page 3













volumes of Ringer’s solution (vehicle) equivalent to that given to the experimental group. To
ascertain the peak blood ethanol concentration (BEC) achieved with this exposure regimen, a
separate group of 6 mice were administered ethanol on their 8th day of pregnancy, utilizing
the previously described paradigm. Thirty minutes after the last ethanol injection (Webster et
al., 1983), 35 ll of tail blood was obtained from each dam and analyzed using an Analox Alcohol
Analyser (Model AM1, Analox Instruments USA Inc., Lunenburg, MA). The average BEC
was 381 ± 13 mg/dl ± SEM. All animal treatment protocols were approved by the University
of North Carolina at Chapel Hill, Division of Laboratory Animal Medicine.
Fetal Specimen Preparation
At the beginning of GD 17, dams were anesthetized via CO2 asphyxiation, followed by cervical
dislocation. Following laparotomy, the uteri were removed and the fetuses were immediately
dissected free of decidua in ice-cold phosphate-buffered-saline (PBS). The fetuses were
examined for the presence of grossly-detectable abnormalities, including ocular defects. For
the ethanol group, selection for MRM scanning was based on identifiable ocular
dysmorphology, a characteristic that is correlative with ethanol-induced CNS deficits in this
mouse model (Cook et al., 1987; Sulik, 2005; Sulik and Johnston, 1983). Twenty-nine fetuses
from 4 different litters were examined, and the 6 most severely affected (based on ocular
abnormalities) were selected for the ethanol-exposed group. For the 6 fetuses (from 4 litters)
in the control group, selection for MRM scanning was based on developmental stage-matching
with the ethanol-exposed specimens. Staging was based on degree of limb, skin, and hair
follicle development (Theiler, 1989). To avoid confounding variables, no more than 2 fetuses
from each litter were selected. After taking photographs to document ocular abnormalities, the
fetuses were fixed for 9 hours in a 20:1 solution of Bouin’s fixative (Sigma-Aldrich, St. Louis,
MO) containing Prohance (Bracco Diagnostics Inc., Princeton, NJ) (Petiet et al., 2007).
Following fixation, the specimens were rinsed briefly in PBS, and then placed in a holding
solution of 200:1 PBS:Prohance. Typically, fetuses were imaged within 48 hours after fixation.
Magnetic Resonance Microscopy
All imaging was performed on a Magnex 7.0T/210 mm bore magnet interfaced to a GE
EXCITE console (Epic 12.0) modified for MR microscopy. Specimens were placed in acrylic
holders and surrounded with fomblin, a perfluorocarbon used to limit dehydration and reduce
susceptibility artifacts. Images were acquired in a 20 mm diameter solenoid radiofrequency
coil using a radiofrequency refocused spin echo sequence (TR=100ms, TE=6.2ms). Images
were acquired with asymmetric partial Fourier sampling (Johnson et al., 2007) into a 512 · 512
· 1024 array resulting in Nyquist limited spatial resolution of 29 lm (voxel volumes of 25 pl).
The total scan time was 4.1 hours for each specimen. Linear Measurements In order to ensure
accurate orientation, each MRM scan was re-aligned in the horizontal, coronal, and sagittal
plane using Image J (Version 1.38·, NIH; http://rsbweb.nih.gov/ij/). This program was also
employed for ascertainment of linear measures. For each fetus, the following were determined:
crown rump length, total head length (anterior to posterior), midsagittal brain length,
frontothalamic distance, brain width (biparietal diameter), olfactory bulb length and width,
ocular diameter, width of the third ventricle, septal region and pituitary gland, and transverse
cerebellar distance (Fig. 1). With the exception of the optic globes, olfactory bulbs, pituitary
and cerebellar diameters, the measurements were taken at the level of the anterior commissure.
All other regions were measured at their widest level. In order to control for the overall ethanol-
induced growth retardation of the brain, the measurements of specific neuroanatomical
structures were normalized to the midsagittal brain length.
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Total body volume for each fetus was computed using the automatic segmentation feature of
ITK-Snap, a software program originally developed at the University of North Carolina, Chapel
Hill (Yushkevich et al., 2006; http://www.itksnap.org). Regional brain volumes for each
specimen were also obtained using ITK-Snap. Selected regions were traced on the MRI slices
via a computer mouse by a single expert trained on fetal mouse neuroanatomy. Horizontal,
coronal, and sagittal planes were used to ensure anatomical accuracy (Fig. 2). Segmentation
boundaries were based on existing fetal mouse atlases (Kaufman, 1992; Schambra, 2008;
Schambra et al., 1992). For the following structures separate volume measurements were made:
the right and left cortex, right and left striatum, right and left hippocampus, septal region, right
and left olfactory bulb, diencephalon, mesencephalon, pons/medulla, cerebellum, pituitary
gland, lateral ventricles, third ventricle, mesencephalic and fourth ventricle, right and left globe
of the eye, and right and left lens. Volume measurements were automatically calculated via
multiplication of the voxel number in each region by the voxel volume (29 lm3). Total brain
volume was determined by summing the cumulative volumes of all brain regions. Intra-rater
reliability was assessed following repeated segmentation of each of the selected structures in
1 control and 1 ethanol-exposed fetus.
Statistics
Crown-rump length and whole brain and body volume data were each analyzed using 2-tailed
t-tests. Linear measurements and regional volumes were analyzed using repeated-measures
ANOVAs. When applicable, post hoc analyses were performed using Fisher’s protected least
significant difference. Intra-rater reliability was analyzed using intraclass correlation
coefficients (ICC). All a levels were set at 0.05.
RESULTS
Linear Measurements
Average crown-rump lengths for the 6 GD 17 ethanolexposed fetuses and 6 developmentally
stage-matched controls were 15.28 ± 0.53 [mean ± standard error of the mean (SEM)] and
16.65 ± 0.36, respectively; illustrating an 8.2% reduction in the crown-rump lengths for the
experimental group (p < 0.05). The linear brain regional measurements were reduced to a
degree corresponding to that of overall brain length, with the exception of transverse cerebellar
distance and width of the third ventricle (Table 1). Following ethanol exposure, the cerebellum
was disproportionately narrow, while the third ventricle was too wide. Ocular measures were
consistent with gross anatomical assessments; those eyes that were determined at the dissecting
microscopic level to be dysmorphic had cross-sectional globe and lens diameters that were
abnormally small. The ocular defects ranged from anophthalmia to slightly aberrant pupil shape
and/or size.
Volume Measurements
Intra-rater reliability measurements were performed using intraclass correlation coefficients
(ICC). The lowest ICC value over all regions was 0.990, with most of the brain regional ICC
values above 0.995, thus demonstrating consistent MRI manual segmentation for all regions.
Total body volume was reduced by 25% in the ethanolexposed, as compared with the control
fetuses (ethanol, 486 ± 33 mm3; control, 650 ± 44 mm3). As expected, based on linear and
total body volume measures, the whole brain of each ethanol-exposed fetus was smaller than
the stage matched controls. This volume reduction averaged 19.5% (p < 0.0001) and was
reflected in significantly smaller volumes of the majority of individual brain regions assessed
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(p < 0.05). The exceptions were the septal region and pituitary, which had volumes similar to
those in the control specimens, and the ventricles, which were larger than their control
counterparts.
To control for the general ethanol-induced growth retardation, each separate region was
normalized to its own total brain volume. This approach has the advantage of being able to
ascertain selective regional vulnerability. After normalization, the repeated measures ANOVA
showed a significant main effect of treatment [F(1, 200) = 25.99, p = 0.0005] and region [F
(20, 200) = 4074.37, p < 0.0001] with a significant interaction between the two [F(20, 200) =
4.55, p < 0.0001]. Further post hoc analyses demonstrated that the right olfactory bulb, right
hippocampus, and cerebellum were significantly smaller in the ethanol-exposed as compared
with control fetuses, with the largest change being present in the cerebellum (Fig. 3). While
reductions were noted in other brain regions as well, they did not reach statistical significance.
In addition, the sizes of both ocular globes and lenses were reduced in the ethanol-exposed
animals, with the right eyes being more severely affected than the left. These analyses also
demonstrated that relative to overall brain volume, the septal region, pituitary, and ventricles
were significantly larger as compared with the control group.
Morphology
Results of examinations of the 3-D reconstructions of the segmented brain regions are
consistent with those for linear and volumetric measures. In addition, they have provided new
insights as exemplified in Fig. 4. Images from a control (A–D) and an ethanol exposed (E–H)
fetus include dorsal and ventral views of the whole brain, as well as ventral and posterior views
of the ventricular system. Apparent in the brain of the ethanol-exposed fetus are distinctly
separate cerebral hemispheres that, from a dorsal view, appear virtually the same as those of
the control. However, from a ventral perspective, more of the septal region can be seen in the
ethanolexposed specimen than in the control (arrow in F). Both the dorsal and ventral views
show that the right olfactory bulb of the ethanol-exposed specimen is abnormally small.
The reconstructed images also greatly facilitate examination of the complex morphology of
the ventricular system. Consistent with the volumetric analyses, as shown in Fig. 4G and 4H,
all of the ventricular spaces in the ethanol-exposed fetus appear larger than in the control. This
is particularly evident for the third ventricle, which is wider in the ethanolexposed specimens
than in the control brains. This finding is also clearly shown in horizontal MRI scans (Fig. 5).
Finally, a feature that, most likely, would not have been detected by examining individual scans
or by using conventional morphological assessment methodologies is abnormal narrowing at
the junction of the mesencephalic and fourth ventricle, as indicated by an arrow in Fig. 4H.
This abnormality was present in 3 of the 6 ethanol-exposed fetuses. In addition to brain
anomalies, in this study, MRI has provided new information regarding abnormalities in other
cranial structures. Because the darkly pigmented eyes of the GD 17 fetal mice can be seen
through the skin of the eyelids, structural anomalies can be ascertained at the dissecting
microscopic level (Fig. 6B). Indeed, as previously noted, for the current investigation the
presence of ocular abnormalities provided a basis for selection as a study subject. Among the
6 ethanol-exposed fetuses, 6 had readily notable unilateral and 5 had bilateral eye defects.
These included 2 right eye colobomas, 2 left eye colobomas, and 1 mouse that was
anophthalmic on the right. The right eyes in all of the ethanol-exposed specimens were at least
slightly microphthalmic, whereas 5 of the 6 left eyes were at least slightly microphthalmic.
The MRM findings were consistent with our gross visual assessments.
In addition, MRM allowed detection of a coloboma extending along the optic nerve, all of the
way to the optic chiasm (Fig. 6D). Although craniofacial defects, other than those involving
the eyes, were not grossly notable in any of the fetuses examined, MRM revealed a very severe
reduction in the size of the nasal cavity in 1 of the 6 ethanol-exposed fetuses examined.
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Sequential coronal scans of this fetus’ head showed extreme stenosis of the nasal passageway,
with only a pinpoint opening at the location shown in Fig. 6C. The lateral walls of this small
nasal cavity were simple and the nasal septum was deviated toward the small side (Fig. 6E).
DISCUSSION
Focusing on insults resulting from acute maternal ethanol exposure on GD 8 in mice, this report
is the first in a series designed to provide MRM-based discovery and documentation of
developmental stage-dependent structural brain abnormalities. As well as confirming an
expected overall ethanol-induced growth retardation, these MRM-based linear and volumetric
analyses have illustrated disproportionate reductions in the olfactory bulbs, hippocampus, and
cerebellum; with the cerebellum being the most severely diminished. These regional size
reductions are accompanied by increased ventricular volumes and a disproportionately large
septal region and pituitary. In addition to quantitative data, MRM made possible the discovery
of dysmorphology in the brains, as well as in other cranial structures, in ethanol-exposed
fetuses.
As discussed below, the noted combination of defects is consistent with known human patterns/
associations of birth defects and is informative for clinical diagnosis.
As illustrated here, MRM is remarkably effective for comprehensive structural analyses. Even
though (because of the cost, the time required for scanning and manual segmentation along
with the limited number of adequate MRM facilities and the expertise required to operate them),
it remains impractical to analyze large numbers of animals with this technique, each animal
can provide a vast amount of data. For the current work, by taking care to stage-match the
control and experimental groups of fetuses, along with utilization of readily identifiable
(ocular) defects as a screening mechanism for affected fetuses, the number of animals required
for discovery of severe structural brain changes was minimized.
That ocular defects result from ethanol exposure at early developmental stages in mice is well
documented (Cook and Sulik, 1986; Cook et al., 1987; Parnell et al., 2006). Indeed, insult
occurring just as the developing eyes begin to form from the diencephalon has previously been
shown to concurrently involve both the brain and eyes (Dunty et al., 2001). Noteworthy is that
the eyes of individual fetuses are frequently asymmetrically affected and the results of this
study suggest that the side on which the eye was most dysmorphic was consistent with that for
the brain. This supports the use of ocular defects as an indicator of coexisting GD 8
ethanolinduced brain dysmorphology. Importantly, it also supports the premise that the reduced
palpebral fissure length, a hallmark of full-blown FAS, is an indicator of reduced globe size
(Parnell et al., 2006) and also reflects brain damage.
The results of previous studies that have explored the genesis of GD 8 ethanol exposure-
induced defects support the current MRM-based findings. Sulik and colleagues (1986) and
Kotch and Sulik (1992) utilized scanning electron microscopy to examine both the face and
forebrain of mouse embryos following GD 8 insult. The pattern of defects observed in GD 10
embryos is illustrated in Fig. 7. In both of the affected embryos shown, as compared to a like-
staged control, the medial nasal prominences are abnormally positioned, being directed away
from the lateral nasal prominences and allowing full view of the developing vomeronasal
organs. In addition, as compared with control, the interior of the forebrain in each of the affected
embryos appears hypoplastic, with the degree of effect being consistent with that for the face.
Excessive mesenchymal (esp. neural crest) and median forebrain cell death noted in these
previous reports are expected to be major contributors to the dysmorphogenesis observed in
the current study. Among the facial defects that have been reported to follow this insult in mice
is cleft lip (Kotch and Sulik, 1992), a finding that would be expected based on the abnormal
Parnell et al. Page 7













proximity of the medial and lateral nasal prominences. These facial prominences must unite
in order for normal lip closure to occur. In addition, recognizing that acute ethanol exposure
on GD 8 also causes a spectrum of heart, great vessel and thymic abnormalities (Daft et al.,
1986), it was previously suggested that the pattern of defects is consistent with that in the
DiGeorge sequence (Sulik et al., 1986). This sequence (OMIM #188400) can result from
genetic (22q11 deletion) or environmental causes and has been associated with maternal
ethanol use in humans (Ammann et al., 1982). As in FASD, mild to moderate learning
difficulties are common in individuals affected with DiGeorge, as are a variety of structural
brain anomalies including a small cerebellar vermis, decreased right cerebellar tissue volume,
enlarged ventricles, and midline anomalies (esp. cavum septum pellucidum) (Shashi et al.,
2004).
In the current study, observation of nasal cavity narrowing/choanal stenosis in concert with
ocular abnormalities (esp. irido-retinal and optic nerve coloboma), and CNS defects provide
additional important diagnostic perspectives. This combination of abnormalities is consistent
with the CHARGE association/syndrome, which consists of ocular coloboma (C), heart
anomaly (H), atresia of choanae (A), retarded mental and somatic growth or development (R),
genital hypoplasia (G), and ear anomalies and/or hearing impairment (E) (OMIM #214800).
In addition to mental retardation, structural abnormalities of the brain are present in the majority
of CHARGE cases (Lin et al. 1990) and include ventricular dilatation, absence/hypoplasia of
the olfactory bulbs and tracts, dysgenesis/hypoplasia of the frontal lobe and optic nerve,
holoprosencephaly, and agenesis of the corpus callosum and septum pellucidum. Overall, the
similarity between the teratogenic endpoints following GD 8 ethanol exposure in mice, as
illustrated in the current and previous analyses, and the features of both the CHARGE
association and DiGeorge sequence is striking. Recognition of these features as part of the
spectrum of defects that prenatal ethanol exposure can cause promises to aid in both pre- and
postnatal diagnosis.
In addition to providing information regarding regional vulnerabilities, the results of the current
study have highlighted the sensitivity of very early stages of CNS development to ethanol-
mediated teratogenesis. While to date the vast majority of research exploring ethanol’s
teratogenic effects on the cerebellum has focused on insult occurring during relatively late
(perinatal) stages of its development, the results of the current study have shown diminished
cerebellar size following acute early (GD 8) ethanol exposure. Identification, in the current
study, of ethanol-induced insult to the hippocampus is similar in that the GD 8 effect is much
earlier than has been commonly expected or examined by others (Bonthius and West, 1991;
Pierce and West, 1987). GD 8 in mice, the time of acute ethanol exposure for this study,
corresponds to the fourth week postfertilization in humans. Clearly, this is a time when ethanol
can cause major structural defects. Since many pregnancies are unplanned and pregnancy
commonly remains unrecognized in the fourth week, strong support has been provided for
FASD prevention directed efforts that stress prepregnancy counseling and education.
In conclusion, MRM technology has made comprehensive structural analyses, as presented
herein, possible. Additionally, it has enabled the work required in order to complete a similar
survey of ethanol-induced structural insults following exposure at multiple other
developmental stages. While it is premature to conclude that the collection of abnormalities
observed in fetuses following GD 8 exposure constitutes a developmental stage-specific
pattern, preliminary results from MRI-based analyses of defects resulting from GD 7 as well
as GD 9 exposure times (Myers et al., 2008; Parnell et al., 2008) differ from those reported
herein. This supports the probability that a unique GD 8-specific pattern of ethanol-induced
dysmorphology exists.
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MRM scans illustrating sites of linear measurements made for GD 17 mouse fetuses. On the
sagittal view shown in (A) the vertical line is placed at the location of the crown-rump measures,
while the lines labeled b–e are at the sites of the corresponding horizontal scan images. The
line in (B) is at the site used for cerebellar diameter determinations. In (C) the lines depict the
following sites of measurement: third ventricle width (line #1); septal width (line #2); brain
width (biparietal diameter) (line #3); frontothalamic distance (line #4); midsagittal brain length
(line #5); head length (line #6). The lines in (D) illustrate sites of olfactory bulb width and
length measures, and in (E) the line is located at the site of measurement for the optic globe
diameter. Bar in (A) = 2 mm; bars in (B–E) = 1 mm.
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Regional segmentation of MRM scans. Images in A, B, and C are representative coronal,
sagittal, and horizontal scans, respectively. Illustrated are color-coded regions that were
manually segmented for each of the brains examined for this study. Computer-generated 3-D
reconstruction of these regions provides a basis for volume determinations and for visualization
of normal and abnormal morphology. Illustrated in (D) is a brain reconstruction with the upper
portion of the right side removed, allowing visualization of interior structures.
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Graphic illustration of ethanol-induced proportional volume changes in GD 17 fetal mouse
brain regions. Significant average volume reductions are indicated by (*), while increases are
indicated by (#).
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3-D reconstructions of control and ethanol-exposed GD 17 fetal mouse brain regions. As
compared to the images of a normal brain (A–D), those from a fetus that had been acutely
exposed to ethanol on GD 8 (E–F) illustrate a visibly small right olfactory bulb (arrow in E)
and excessive space between the bulbs, a relatively large ventral midline view of the septal
region (arrow in F); notable enlargement of the third ventricle (arrow in G) as observed from
a ventral view of the reconstructed ventricular system; and narrowing of the cerebral aqueduct
(arrow in H) as observed in a posterior view of the ventricular system.
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Horizontal MRM scans illustrate abnormalities in an ethanol exposed fetal brain (B) as
compared with that of a control (A). At the level of the anterior commissure (arrowheads in A
and B), the third ventricle (arrow in B) is notably larger in the ethanol-exposed fetus. Also
notable is the abnormal right olfactory bulb.
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Optic abnormalities and choanal stenosis in alcohol-exposed fetuses. Microphthalmia and
irideo-retinal coloboma (arrow in B) are evident in GD 17 ethanol-exposed fetuses. [Compare
the affected left eye in (B) to the normal left eye of a control GD 17 fetus in (A).] Additionally,
MRM revealed an optic nerve coloboma in the right eye of an ethanol-exposed fetus (arrow in
D). Of particular note is unilateral choanal stenosis in an alcohol-exposed fetus. A coronal
MRM scan (C) at the level indicated by the line in (B) illustrates a pinhole-like opening (arrow),
representing the extreme narrowing of the right choana. A horizontal scan (E) of the fetus in
(C) illustrates the simple contours of the small right nasal cavity (arrow). This fetus also
presented with anophthalmia on its right side.
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Scanning electron micrographs illustrate face and brain defects in GD 10 embryos following
GD 8 maternal ethanol treatment. Comparison to a control embryo (A, B) illustrates abnormal
upper midface and forebrain contours in the 2 affected embryos shown (C–F). In both affected
embryos the medial nasal prominences (M) are abnormally positioned, being directed away
from the lateral nasal prominences (L) and allowing full view of the developing vomeronasal
organs (arrow). As compared with control, the interior of the forebrain in each of the affected
embryos appears hypoplastic, with the degree of affect being consistent with that for the face.
C = corpus striatum, curved arrow = optic stalk. Bars = 100 lm (modified from Sulik et al.,
1986).
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Table 1
Data are reported as a percentage of the head length as measured anterioposteriorly and are ± the standard error of the
mean. Range of measurements in each region and group is indicated in parentheses.
Measurement Control EtOH-Exposed
Mid-sagittal brain length 81.7 ± 0.8 (80.2–85.2) 82.9 ± 0.8 (79.0–84.6)
Cortical brain width 55.0 ± 0.6 (52.5–57.1) 54.8 ± 0.5 (53.4–56.8)
Frontothalamic distance 39.4 ± 0.2 (38.7–40.8) 39.9 ± 0.6 (37.6–41.7)
Transverse cerebellar distance 50.3 ± 0.4 (48.5–51.1) 48.4 ± 0.2 (48.0–49.1)*
Olfactory bulb length
 Right 11.5 ± 0.3 (10.7–12.3) 11.0 ± 0.4 (9.7–12.4)
 Left 11.5 ± 0.3 (10.4–12.3) 10.7 ± 0.2 (9.9–11.3)
Olfactory bulb width
 Right 10.0 ± 0.1 (9.7–10.4) 10.1 ± 0.3 (8.9–10.9)
 Left 10.1 ± 0.3 (9.3–11.1) 10.5 ± 0.2 (10.0–11.3)
Septal region width 13.5 ± 0.1 (13.2–13.9) 14.1 ± 0.3 (13.2–14.8)
Pituitary gland width 14.4 ± 0.4 (12.9–15.5) 15.3 ± 0.2 (14.3–16.1)
Third ventricle width 2.1 ± 0.001 (1.7–2.6) 3.0 ± 0.002 (2.6–3.7)*
Ocular diameter
 Right 14.1 ± 0.1 (13.7–14.4) 10.8 ± 2.3 (0–14.2)
 Left 14.1 ± 0.2 (13.1–14.8) 13.8 ± 0.5 (11.5–15.1)
*
= significant difference between ethanol-treated and controls. n = 6 specimens in each group.
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